Ultomiris

Made by

• Alexion

Active Ingredient

Ravulizumab (genetical recombination)

Prospectus

Approval date

2019/6/18

Treats

• Paroxysmal nocturnal hemoglobinuria
• Atypical hemolytic uremic syndrome

Dosages

• ULTOMIRIS for Intravenous Infusion - 699570円／瓶

• ULTOMIRIS for Intravenous Infusion -

• ULTOMIRIS for Intravenous Infusion -